BIRMINGHAM, AL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SOUTHERN RESEARCH INSTITUTE, founded in 1941, is a mid-sized nonprofit in the Science & Technology sector that reported $50.4M in total revenue in fiscal year 2024. Net assets of $181.6M represent 43 months of operating reserves.
TO OFFER RESEARCH AND TECHNOLOGY SERVICES TO SUPPORT THE LIFE SCIENCES, ENERGY, AND ENVIRONMENTAL PROTECTION INDUSTRIES. THE ORGANIZATION PURSUES ENTREPRENEURIAL AND COLLABORATIVE INITIATIVES TO DEVELOP AND MAINTAIN A PIPELINE OF INTELLECTUAL PROPERTY AND INNOVATIVE TECHNOLOGIES THAT CONTRIBUTE TO THE GROWTH OF THE ORGANIZATION AND POSITIVELY IMPACT REAL-WORLD PROBLEMS.
SCIENTIFIC PLATFORMS HAS ACCOMPLISHED INNOVATIVE RESEARCH IN THE AREAS OF CANCER, INFECTIOUS DISEASE, AND NEUROSCIENCE. WITH A FOCUS ON THE DISCOVERY OF NEW, SMALL-MOLECULE THERAPEUTICS AND THE...
SCIENTIFIC PLATFORMS HAS ACCOMPLISHED INNOVATIVE RESEARCH IN THE AREAS OF CANCER, INFECTIOUS DISEASE, AND NEUROSCIENCE. WITH A FOCUS ON THE DISCOVERY OF NEW, SMALL-MOLECULE THERAPEUTICS AND THE UNDERSTANDING OF HOW THESE MOLECULES WORK, DRUG DISCOVERY CARRIES OUT TRANSLATIONAL SCIENCE DESIGNED TO INVENT SMALL MOLECULES AND ADVANCE THEM FROM THE DESIGN STAGE TO THE CLINIC. GOVERNMENT FUNDING SUPPORTS OUR EFFORTS IN PIONEERING NEW SCIENTIFIC AREAS OF DRUG DISCOVERY. THE SCIENTIFIC PLATFORMS' STAFF PROVIDES EXPERTISE IN MEDICINAL CHEMISTRY, MOLECULAR BIOLOGY, BIOCHEMISTRY, AND HIGH-THROUGHPUT SCREENING TECHNOLOGIES, ALL FOCUSED ON MAKING DISCOVERIES THAT WILL CONTRIBUTE TO IMPROVING HUMAN HEALTH. THE SCIENTIFIC PLATFORMS' TEAM HAS BEEN VERY EFFECTIVE IN ITS EFFORTS AND HAS DISCOVERED MORE THAN 20 DRUGS THAT HAVE ENTERED CLINICAL TRIALS AND SIX DRUGS THAT HAVE BEEN APPROVED BY THE FDA FOR USE IN THE TREATMENT OF CANCER.
CRO SERVICES PROVIDES DRUG DISCOVERY AND PRE-CLINICAL DRUG DEVELOPMENT TO PHARMACEUTICAL AND BIOTECHNOLOGY ON AN OUTSOURCED BASIS. SOUTHERN RESEARCH INSTITUTE HAS CAPABILITIES IN ALL PHASES OF THE...
CRO SERVICES PROVIDES DRUG DISCOVERY AND PRE-CLINICAL DRUG DEVELOPMENT TO PHARMACEUTICAL AND BIOTECHNOLOGY ON AN OUTSOURCED BASIS. SOUTHERN RESEARCH INSTITUTE HAS CAPABILITIES IN ALL PHASES OF THE EARLY-STAGE DRUG DISCOVERY AND DEVELOPMENT PROCESS AND PROVIDES CLIENTS WITH COMPREHENSIVE SERVICES AND SUPPORT TO ASSIST THEM IN STREAMLINING THEIR CUSTOM DRUG DISCOVERY AND DEVELOPMENT PROGRAMS. SOME OF SOUTHERN RESEARCH INSTITUTE'S SIGNIFICANT PRE-CLINICAL RESEARCH ACCOMPLISHMENTS INCLUDE: DEMONSTRATED THE EFFICACY OF COMBINATION CHEMOTHERAPY IN MICE, LEADING THE WAY FOR THE DEVELOPMENT OF THERAPEUTIC APPROACHES WITH IMPROVED CLINICAL OUTCOMES IN CERTAIN CANCERS, PERFORMED PRE-CLINICAL DRUG DEVELOPMENT EVALUATIONS AND ANALYSES ON APPROXIMATELY HALF OF THE FDA-APPROVED CANCER THERAPEUTICS CURRENTLY ON THE MARKET, AND CONTRIBUTED TO THE DEVELOPMENT OF THE FIRST DRUG DELIVERY TECHNOLOGY FOR THE EXTENDED RELEASE OF SYNTHETIC AGENTS THAT PROMOTE THE TREATMENT OF PROSTATE CANCER.
SOUTHERN RESEARCH'S STEM EDUCATION OUTREACH PROGRAM IS INVOLVED IN A WIDE VARIETY OF PROGRAMS THAT IMPACT STUDENTS AND TEACHERS IN ALABAMA. THE MISSION OF SR'S STEM PROGRAM IS TO ENHANCE 6TH THROUGH...
SOUTHERN RESEARCH'S STEM EDUCATION OUTREACH PROGRAM IS INVOLVED IN A WIDE VARIETY OF PROGRAMS THAT IMPACT STUDENTS AND TEACHERS IN ALABAMA. THE MISSION OF SR'S STEM PROGRAM IS TO ENHANCE 6TH THROUGH 12TH GRADE STEM EDUCATION BY DRAWING UPON THE EXPERTISE AND SCHOLARLY CONTRIBUTIONS OF THE SOUTHERN RESEARCH COMMUNITY. WE AIM TO DEFINE AND EXEMPLIFY EFFECTIVE STEM EDUCATION TO MAXIMIZE STUDENTS' READINESS TO EXCEL IN A RAPIDLY CHANGING WORLD. WE ARE WORKING TO ACHIEVE OUR EDUCATION MISSION BY ENGAGING STUDENTS AND TEACHERS IN STEM ACTIVITIES THROUGH SUMMER LEARNING PROGRAMS, FIELD TRIPS, AFTER-SCHOOL PROGRAMING, STEM COMPETITIONS AND SCIENCE FAIRS, INTERNSHIPS, AND PROFESSIONAL DEVELOPMENT WORKSHOPS FOR STEM EDUCATORS. OUR PRIMARY OBJECTIVE IS TO EMBOLDEN STUDENTS WHO POSSESS A PASSION FOR INNOVATION AND DISCOVERY TO PURSUE THEIR INTERESTS AND STRENGTHEN THE STEM COMMUNITY. SOUTHERN RESEARCH IS COMMITTED TO FOSTERING CREATIVITY AND IMPACTING THE FUTURE GENERATION.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $50,381,130 | $49,759,960 | +0.0% |
| Expenses | $49,830,156 | $55,964,770 | -0.1% |
| Net Income | $550,974 | $-6,204,810 | -1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| SID J TRANT | INTERIM DIRECTOR | 1.00 |
Director
|
$0 | $91,451 | $900,706 |
| ABISHEK KULSHRESHTHA | CHIEF BUSINESS OFFICER (THRU 3/24) | 40.00 |
Director
|
$144,437 | $4,669 | $149,106 |
| FINIS ST JOHN VI | DIRECTOR (THRU 4/24) | 1.00 |
Director
|
$0 | $51,413 | $580,377 |
| RAY WATTS | CHAIRMAN | 1.00 |
Director
|
$0 | $95,387 | $809,164 |
| CHRISTOPHER S BROWN PHD | DIRECTOR | 1.00 |
Director
|
$0 | $101,260 | $525,178 |
| ANUPAM AGARWAL | DIRECTOR | 1.00 |
Director
|
$0 | $61,356 | $308,357 |
| REGINA BENJAMIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MIKE BROCK | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BOBBIE KNIGHT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMEY MCMAHON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| GENE RUFFNER PAGE JR | VICE CHAIRMAN | 1.00 |
Director
|
$0 | $0 | $0 |
| JEFFREY PEOPLES | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SCOTT PHELPS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KEN SIMON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LEE STYSLINGER III | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NEEL VARSHNEY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSHUA CARPENTER | PRESIDENT AND CEO (THRU 12/24) | 40.00 |
Officer
|
$412,848 | $32,413 | $445,261 |
| CORRINE AUGELLI-SZAFRAN | VP SCIENTIFIC PLATFORMS | 40.00 |
Officer
|
$291,552 | $4,826 | $296,378 |
| DAVID RUTLEDGE | SENIOR ADVISOR OF FINANCE | 40.00 |
Officer
|
$253,474 | $32,634 | $286,108 |
| MONICA W MASON | INTERIM VP CRO SERVICES | 40.00 |
Officer
|
$238,113 | $41,238 | $279,351 |
| RICARDO BRITO | CHIEF OF STAFF | 40.00 |
Officer
|
$187,879 | $13,918 | $201,797 |
| HARRY LEDEBUR JR | CHIEF OPERATING OFFICER | 40.00 |
Officer
|
$232,271 | $30,500 | $262,771 |
| ANNA BRANTLEY FRY | VP OF PEOPLE AND COMMUNITY (THRU 6/24) | 40.00 |
Officer
|
$211,854 | $19,615 | $231,469 |
| RAY COLEMAN LOPER | INTERIM CEO & CFO | 32.00 |
Officer
|
$104,434 | $116 | $104,550 |
| LESTER SMITH JR | CHIEF FINANCIAL OFFICER (THRU 6/24) | 40.00 |
Officer
|
$227,390 | $30,535 | $257,925 |
| OLIVER HAMPTON | CHIEF DATA OFFICER | 40.00 |
Highest
|
$383,042 | $33,700 | $416,742 |
| KHALILAH BROWN | CHIEF MEDICAL OFFICER | 40.00 |
Highest
|
$247,279 | $39,834 | $287,113 |
| MARIANNE P NURRE | SR. CONTROLLER | 40.00 |
Highest
|
$201,521 | $31,547 | $233,068 |
| JENNIFER PICKENS | DIRECTOR OF INFECTIOUS DISEASE | 40.00 |
Highest
|
$194,308 | $28,552 | $222,860 |
| FUSATAKA KOIDE | DIRECTOR OF BUSINESS DEVELOPMENT | 40.00 |
Highest
|
$241,585 | $34,283 | $275,868 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $50,381,130 | $49,830,156 | $238,738,191 | $550,974 |
| 2023 | $49,759,960 | $55,964,770 | $242,110,174 | $-6,204,810 |
| 2022 | $149,651,608 | $57,118,873 | $211,179,645 | $92,532,735 |
| 2021 | $85,654,710 | $77,111,881 | $124,270,036 | $8,542,829 |
Compare SOUTHERN RESEARCH INSTITUTE with other nonprofits in Alabama and across the country.